MINI fails to keep up with AIM index – Miton UK Micro Cap has published results for the year ended 30 April 2018. Over the year, the NAV returned 8.4%. This compares with the AIM All-Share Index, which returned 10.7% (AIM stocks account for three quarters of the portfolio). This performance is somewhat higher than the returns on other […]
Investment Trust Insider on how to grow trusts James Carthew: imponderable questions in quest for scale Last week I addressed the uphill battle Ashoka India Equity (AIE) faces if it wants to expand, having raised just £46.5 million in its flotation. It is by no means the smallest fund out there, however. Many of the very smallest funds […]
Regional REIT plans bond issue – Regional REIT has launched an offer of 4.5% sterling bonds due 6 August 2024. The Bonds will pay a fixed rate of interest of 4.5% per annum. Interest will be payable semi-annually in arrears in equal instalments. The Bonds have a minimum initial subscription amount of GBP2,000 and are available in […]
Supermarket Income REIT buys Sheffield Morrisons store – Supermarket Income REIT has acquired a Morrisons’ supermarket in Sheffield from Opus North for GBP51.7 million (excluding acquisition costs), reflecting a net initial yield of 4.9%. The supermarket is located on an 8.4-acre site in the historic and prominent Hillsborough Barracks. It comprises a 113,000 sq ft Morrisons’ […]
NB Private Equity sets new dividend target – NB Private Equity Partners Limited has just declared its second semi-annual dividend for 2018. The payment of $0.28 per share is a $0.03 increase from the company’s prior dividend and, on an annualised basis, this dividend payment represents a dividend yield of 4.1%. Going forward, NBPE has announced a target yield of 3.0% […]
FDA accepts HBM investee Immunomedics’ breast cancer drug filing US biotech Immunomedics (Nasdaq:IMMU), a top 10 holding for Swiss-listed HBM Healthcare (2.5% of NAV), has reported that the US FDA has accepted its regulatory application for the antibody-drug conjugate sacituzumab govitecan and granted priority review with an action date of 18 January 2019. The application […]
Trust favourite Biogen preps for detailed Alzheimer’s trial results Trust favourite Biogen (Nasdaq: BIIB), the largest single holding for Biotech Growth Trust (BIOG, 11.7% of NAV) and widely held stock among other sector specialist collective vehicles – will with its joint venture partner Eisai shortly disclose detailed results from a Phase II study of the […]
Polar Capital Healthcare rejigs portfolio Polar Capital Global Healthcare Trust (PCGH) has disclosed a significant portfolio rejig in its end June monthly update, noting that it had sold a number of positions and increased its cash holdings partly on concerns about increased volatility in the equity markets and the potential for a market correction over the summer. […]
Polar Capital Tech beats its benchmark again – Polar Capital Technology Trust has reported another year of outperformance. In the year to 30 April 2017, NAV rose by just over 56.0%, over the year to end April 2018, it rose by another 22.7%, taking NAV per share to 1,159.69p and the net assets of the company to £1,551.6m. The share price […]
Chelverton UK Dividend hit by Conviviality and Fairpoint – Chelverton UK Dividend Trust has published results for the year ended 30 April 2018. The net asset value as at 30 April 2018 was 249.61p (2017: 248.35p), an increase over the year of 0.51%. The shares benefited from a narrowing of the discount and, at the end of […]
